Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives

Author(s): Imran Shahid and Qaiser Jabeen

DOI: 10.2174/9789815123432123010014

Global Health Sector Strategy (2016-2021) Toward Ending Hepatitis-C: Promises, Policies, and Progress

Pp: 343-369 (27)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

The worldwide prevalence of the hepatitis C virus takes a heavy toll on lives, communities, and health systems. Every year more than 4 million peoples die from hepatitis C-related liver cancers and cirrhosis- a mortality tool comparable to that of HIV and tuberculosis. It needs for a global health sector strategy stems from the scale and complexity of the hepatitis C epidemic, along with growing recognition of its massive public health burden, and the huge opportunities for action. It is a golden time now to establish a coherent public health hepatitis C response that prioritizes effective interventions, promotes service delivery approaches that ensure quality and equity to test and treat every hepatitis C infected individual, takes programs to achieve the sustained impact of hepatitis C diagnostics and therapeutics at the population level, and establishes clear stakeholder responsibility and accountability. There are unprecedented opportunities to act while ending the hepatitis C epidemic and are feasible with the tools and approaches currently available and in the pipeline. For the greatest impact, these opportunities should be combined and tailored for specific populations, locations, and settings. New opportunities and health sector policies provide a ray of hope for the elimination of hepatitis C as a public health threat. In this book chapter, we will highlight the goals, aims, opportunities, and barriers to a coherent public health policy for hepatitis C effective interventions at screening, diagnostic, and therapeutic scale in general and vulnerable hepatitis C infected populations and their consensus implementations to healthcare systems.

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books